Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the launch of IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs, ...
IDEXX Laboratories, Inc. IDXX has unveiled the IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs. This affordable and accessible blood test can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results